Panacea Biotec today said it has received an order worth USD 13.49 million for supplying EasyFive-TT vaccine to global health agency PAHO.
The 5-in-1 vaccine protects infants from 5 potentially deadly diseases: Haemophilus Influenza type B (the bacteria that causes meningitis, pneumonia and otitis), Whooping Cough, Tetanus, Hepatitis B and Diphtheria.
In a BSE filing, Panacea said it has been elected for the supply of pentavalent vaccine DTP-HepB-Hib by the Pan American Health Organisation.
"The company has been awarded for supply of 5.99 million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 and 2016 worth USD 13.49 million (equivalent to around Rs. 83.52 crore) to meet the requirements of global immunisation program," it added.
Panacea Biotec Joint MD Rajesh Jain said: "We are pleased with this opportunity of supplying Easyfive-TT vaccines to meet the requirements of PAHO once again after a gap of 3 years."
PAHO is a specialised health agency of the Inter-American System and serves as the Regional Office for the Americas of the World Health Organization.
